The Latin America, Middle East and Africa Microtome Market would witness market growth of 11.9% CAGR during the forecast period (2022-2028).
The detection of biomarkers for early diagnosis, therapy prediction, and the prognosis is a prominent emphasis in cancer research. Validation of target proteins on clinical samples is therefore critical. Without a microtome, this is impossible. Microtomes, both semi-automated and completely automated, are frequently used to harvest tiny sections of tissues and identify the presence of tumor cells in the body. Pathologists use the analysis of these biopsy tissues to determine the type of cancer, as well as its stage and extent of metastasis.
The number of cancer patients in the Gulf States and the Eastern Mediterranean Region (EMR) is increasing alarmingly. Long-term predictions show a 1.8-fold increase in cancer incidence by 2030. In addition to liver and bladder cancer in Egypt, the age-standardized incidence rate of the top five cancers in Islamic nations has increased over the last ten years. In the Gulf States, as well as Algeria, Lebanon, Jordan, the Palestinian Territories, Morocco, and Tunisia, lung cancer is the most frequent malignancy among men. In 2020, there are expected to be 29,576 new cases of lung cancer, up from 16,596 in 2008. Increased cigarette smoking and other tobacco products among young individuals are blamed for the increased burden.
Despite slow growth in recent decades, the MENA area has made tremendous progress in terms of morbidity and mortality trends, as well as other health indicators. The expansion of health services and public health programs, as well as educational and socioeconomic improvements, is substantially responsible for these accomplishments in health. The UAE has a solid healthcare infrastructure as one of the most economically developed and diversified economies in the Middle East. The UAE government has made building a world-class healthcare infrastructure a primary priority, and as a result, the industry has grown and expanded tremendously in recent years.
The Brazil market dominated the LAMEA Microtome Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $14.5 million by 2028. The Argentina market is anticipated to grow at CAGR of 12.5% during (2022 - 2028). Additionally, The UAE market would showcase a CAGR of 11.7% during (2022 - 2028).
Based on Product, the market is segmented into Instruments (Rotary, Cryostat, Vibrating, and Others) and Accessories. Based on Technology, the market is segmented into Fully Automated, Semi-automated, and Manual. Based on Application, the market is segmented into Disease Diagnosis and Medical Research. Based on End-user, the market is segmented into Hospital Laboratories, Clinical Laboratories, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Microtome Market is Predict to reach $605.5 Million by 2028, at a CAGR of 6.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation, Cardinal Health, Inc., PHC Holdings Corporation, Boeckeler Instruments, Inc., Bright Instruments Limited, Erma, Inc., Histo-line Laboratories, microTec Laborgeräte GmbH, MEDITE Medical GmbH, and Sakura Finetek USA, Inc.
By Product
By Technology
By Application
By End User
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
